CXCR3: Latest evidence for the involvement of chemokine signaling in bone cancer pain

Experimental Neurology

Volumn 265, Issue , 2015, Pages 176-179

  Guo, Genhua ^a   Gao, Feng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Akt; Bone cancer pain; Chemokine; Chronic pain; CXCR3; ERK

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTROPHIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE A; RAF PROTEIN; VANILLOID RECEPTOR 1; CHEMOKINE; CXCR3 PROTEIN, HUMAN;

BONE CANCER; CANCER PAIN; CXCR3 GENE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; GENE; GENE OVEREXPRESSION; GENETIC CORRELATION; HUMAN; INFLAMMATION; LIGAND BINDING; NOCICEPTIVE PAIN; NONHUMAN; NOTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; SENSITIZATION; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL GANGLION; TISSUE DISTRIBUTION; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT; ANIMAL; BONE NEOPLASMS; COMPLICATION; METABOLISM; PAIN; PHYSIOLOGY;

ANIMALS; BONE NEOPLASMS; CHEMOKINES; HUMANS; PAIN; RECEPTORS, CXCR3; SIGNAL TRANSDUCTION;

EID: 84923011216     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.02.003     Document Type: Note

References (73)

1. Arenberg D.A., Zlotnick A., Strom S.R., Burdick M.D., Strieter R.M. The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model. Cancer Immunol. Immunother. 2001, 49:587-592.
2. Asai H., Ozaki N., Shinoda M., Nagamine K., Tohnai I., Ueda M., Sugiura Y. Heat and mechanical hyperalgesia in mice model of cancer pain. Pain 2005, 117:19-29.
3. Baamonde A., Curto-Reyes V., Juarez L., Meana A., Hidalgo A., Menendez L. Antihyperalgesic effects induced by the IL-1 receptor antagonist anakinra and increased IL-1beta levels in inflamed and osteosarcoma-bearing mice. Life Sci. 2007, 81:673-682.
4. Bevan S., Geppetti P. Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci. 1994, 17:509-512.
5. Bhangoo S., Ren D., Miller R.J., Henry K.J., Lineswala J., Hamdouchi C., Li B., Monahan P.E., Chan D.M., Ripsch M.S., White F.A. Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol. Pain 2007, 3:38.
6. Biber K., Dijkstra I., Trebst C., De Groot C.J., Ransohoff R.M., Boddeke H.W. Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia. Neuroscience 2002, 112:487-497.
7. Bloom A.P., Jimenez-Andrade J.M., Taylor R.N., Castaneda-Corral G., Kacz-marska M.J., Freeman K.T., Coughlin K.A., Ghilardi J.R., Kuskowski M.A., Mantyh P.W. Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers. J. Pain 2011, 12:698-711.
8. Brahimi-Horn M.C., Pouyssegur J. Oxygen, a source of life and stress. FEBS Lett. 2007, 581:3582-3591.
9. Brahimi-Horn M.C., Chiche J., Pouyssegur J. Hypoxia and cancer. J. Mol. Med. (Berl) 2007, 85:1301-1307.
10. Brahimi-Horn M.C., Chiche J., Pouyssegur J. Hypoxia signaling controls metabolic demand. Curr. Opin. Cell Biol. 2007, 19:223-229.
11. Bu H., Shu B., Gao F., Liu C., Guan X., Ke C., Cao F., Hinton A.O., Xiang H., Yang H., Tian X., Tian Y. Spinal IFN-γ-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models. Breast Cancer Res. Treat. 2014, 143:255-263.
12. Cambien B., Karimdjee B.F., Richard-Fiardo P., Bziouech H., Barthel R., Millet M.A., Martini V., Birnbaum D., Scoazec J.Y., Abello J., Al Saati T., Johnson M.G., Sullivan T.J., Medina J.C., Collins T.L., Schmid-Alliana A., Schmid-Antomarchi H. Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism. Br. J. Cancer 2009, 100:1755-1764.
13. Carr F.B., Géranton S.M., Hunt S.P. Descending controls modulate inflammatory joint pain and regulate CXC chemokine and iNOS expression in the dorsal horn. Mol. Pain 2014, 10:39.
14. Coleman R.E. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res. 2006, 12:6243-6249.
15. Constantin C.E., Mair N., Sailer C.A., Andratsch M., Xu Z.Z., Blumer M.J., Scherbakov N., Davis J.B., Bluethmann H., Ji R.R., Kress M. Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J. Neurosci. 2008, 28:5072-5081.
16. Costantini M., Ripamonti C., Beccaro M., Montella M., Borgia P., Casella C., Miccinesi G. Prevalence, distress, management, and relief of pain during the last 3months of cancer patients' life. Results of an Italian mortality follow-back survey. Ann. Oncol. 2009, 20:729-735.
17. de Jong E.K., de Haas A.H., Brouwer N., van Weering H.R., Hensens M., Bechmann I., Pratley P., Wesseling E., Boddeke H.W., Biber K. Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3. J. Neurochem. 2008, 105:1726-1736.
18. Ehlert J.E., Addison C.A., Burdick M.D., Kunkel S.L., Strieter R.M. Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping. J. Immunol. 2004, 173:6234-6240.
19. Fu E.S., Zhang Y.P., Sagen J., Candiotti K.A., Morton P.D., Liebl D.J., Bethea J.R., Brambilla R. Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain 2010, 148:509-518.
20. Geis C., Graulich M., Wissmann A., Hagenacker T., Thomale J., Sommer C., Schafers M. Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain. Neuroscience 2010, 169:463-474.
21. Ghilardi J.R., Röhrich H., Lindsay T.H., Sevcik M.A., Schwei M.J., Kubota K., Halvorson K.G., Poblete J., Chaplan S.R., Dubin A.E., Carruthers N.I., Swanson D., Kuskowski M., Flores C.M., Julius D., Mantyh P.W. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J. Neurosci. 2005, 25:3126-3131.
22. Gu X., Zheng Y., Ren B., Zhang R., Mei F., Zhang J., Ma Z. Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-alpha expression in a mouse model. Mol. Pain 2010, 6:64.
23. Guan X.H., Fu Q.C., Shi D., Bu H.L., Song Z.P., Xiong B.R., Shu B., Xiang H.B., Xu B., Manyande A., Cao F., Tian Y.K. Activation of spinal chemokine receptor CXCR3 mediates bone cancer pain through an Akt-ERK crosstalk pathway in rats. Exp. Neurol. 2015, 263:39-49.
24. Halvorson K.G., Kubota K., Sevcik M.A., Lindsay T.H., Sotillo J.E., Ghilardi J.R., Rosol T.J., Boustany L., Shelton D.L., Mantyh P.W. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res. 2005, 65:9426-9435.
25. Han Y., Li Y., Xiao X., Liu J., Meng X.L., Liu F.Y., Xing G.G., Wan Y. Formaldehyde up-regulates TRPV1 through MAPK and PI3K signaling pathways in a rat model of bone cancer pain. Neurosci. Bull. 2012, 28:165-172.
26. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
27. Hang L.H., Shao D.H., Chen Z., Chen Y.F., Shu W.W., Zhao Z.G. Involvement of spinal CC chemokine ligand 5 in the development of bone cancer pain in rats. Basic Clin. Pharmacol. Toxicol. 2013, 113:325-328.
28. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000, 98:585-598.
29. Hu J.H., Yang J.P., Liu L., Li C.F., Wang L.N., Ji F.H., Cheng H. Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord. Brain Res. 2012, 1465:1-9.
30. Hu J.H., Zheng X.Y., Yang J.P., Wang L.N., Ji F.H. Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats. Neurosci. Lett. 2012, 517:60-63.
31. Hu X.M., Liu Y.N., Zhang H.L., Cao S.B., Zhang T., Chen L.P., Shen W. CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats. J. Neurochem. Nov 13 2014, 10.1111/jnc.12985.
32. Jahr H., van Driel M., van Osch G.J., Weinans H., van Leeuwen J.P. Identification of acid-sensing ion channels in bone. Biochem. Biophys. Res. Commun. 2005, 337:349-354.
33. Jenh C.H., Cox M.A., Kaminski H., Zhang M., Byrnes H., Fine J., Lundell D., Chou C.C., Narula S.K., Zavodny P.J. Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. J. Immunol. 1999, 162:3765-3769.
34. Jimenez-Andrade J.M., Bloom A.P., Stake J.I., Mantyh W.G., Taylor R.N., Freeman K.T., Ghilardi J.R., Kuskowski M.A., Mantyh P.W. Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J. Neurosci. 2010, 30:14649-14656.
35. Jimenez-Andrade J.M., Ghilardi J.R., Castaneda-Corral G., Kuskowski M.A., Mantyh P.W. Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain 2011, 152:2564-2574.
36. Kawada K., Sonoshita M., Sakashita H., Takabayashi A., Yamaoka Y., Manabe T., Inaba K., Minato N., Oshima M., Taketo M.M. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res. 2004, 64:4010-4017.
37. Kawada K., Hosogi H., Sonoshita M., Sakashita H., Manabe T., Shimahara Y., Sakai Y., Takabayashi A., Oshima M., Taketo M.M. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene 2007, 26:4679-4688.
38. Krishtal O.A., Pidoplichko V.I. A receptor for protons in the nerve cell membrane. Neuroscience 1980, 5:2325-2327.
39. Lasagni L., Francalanci M., Annunziato F., Lazzeri E., Giannini S., Cosmi L., Sagrinati C., Mazzinghi B., Orlando C., Maggi E., Marra F., Romagnani S., Serio M., Romagnani P. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 2003, 197:1537-1549.
40. Lee J.H., Kim H.N., Kim K.O., Jin W.J., Lee S., Kim H.H., Ha H., Lee Z.H. CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis. Cancer Res. 2012, 72:3175-3186.
41. Liou J.T., Yuan H.B., Mao C.C., Lai Y.S., Day Y.J. Absence of C-C motif chemokine ligand 5 in mice leads to decreased local macrophage recruitment and behavioral hypersensitivity in a murine neuropathic pain model. Pain 2012, 153:1283-1291.
42. - cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J. Cell. Physiol. 2008, 215:593-602.
43. Ma X., Norsworthy K., Kundu N., Rodgers W.H., Gimotty P.A., Goloubeva O., Lipsky M., Li Y., Holt D., Fulton A. CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model. Mol. Cancer Ther. 2009, 8:490-498.
44. Mantyh W.G., Jimenez-Andrade J.M., Stake J.I., Bloom A.P., Kaczmarska M.J., Taylor R.N., Freeman K.T., Ghilardi J.R., Kuskowski M.A., Mantyh P.W. Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience 2010, 171:588-598.
45. Mantyh P.W., Koltzenburg M., Mendell L.M., Tive L., Shelton D.L. Antagonism of nerve growth factor-TrkA signaling and the relief of pain. Anesthesiology 2011, 115:189-204.
46. Nagae M., Hiraga T., Yoneda T. Acidic microenvironment created by osteoclasts causes bone pain associated with tumor colonization. J. Bone Miner. Metab. 2007, 25:99-104.
47. Pevida M., Gonzalez-Rodriguez S., Lastra A., Garcia-Suarez O., Hidalgo A., Menendez L., Baamonde A. Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: a role for astroglia and microglia. Cell. Mol. Neurobiol. 2013, 34:143-156.
48. Price T.J., Louria M.D., Candelario-Soto D., Dussor G.O., Jeske N.A., Pat-wardhan A.M., Diogenes A., Trott A.A., Hargreaves K.M., Flores C.M. Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion. BMC Neurosci. 2005, 6:4.
49. - current and chemotaxis in murine microglia. J. Immunol. 2002, 168:3221-3226.
50. Reeh P.W., Steen K.H. Tissue acidosis in nociception and pain. Prog. Brain Res. 1996, 113:143-151.
51. Ren B.X., Gu X.P., Zheng Y.G., Liu C.L., Wang D., Sun Y.E., Ma Z.L. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model. Anesthesiology 2012, 116:122-132.
52. Schmitz K., Pickert G., Wijnvoord N., Häussler A., Tegeder I. Dichotomy of CCL21 and CXCR3 in nerve injury-evoked and autoimmunity-evoked hyperalgesia. Brain Behav. Immun. 2013, 32:186-200.
53. Seidlitz E.P., Sharma M.K., Singh G. Extracellular glutamate alters mature osteoclast and osteoblast functions. Can. J. Physiol. Pharmacol. 2010, 88:929-936.
54. Sevcik M.A., Ghilardi J.R., Peters C.M., Lindsay T.H., Halvorson K.G., Jonas B.M., Kubota K., Kuskowski M.A., Boustany L., Shelton D.L., Mantyh P.W. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain 2005, 115:128-141.
55. Sharma M.K., Seidlitz E.P., Singh G. Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem. Biophys. Res. Commun. 2010, 391:91-95.
56. Shin S.Y., Nam J.S., Lim Y., Lee Y.H. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines. J. Biol. Chem. 2010, 285:30731-30740.
57. Shinoda M., Ogino A., Ozaki N., Urano H., Hironaka K., Yasui M., Sugiura Y. Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain. J. Pain 2008, 9:687-699.
58. Soto H., Wang W., Strieter R.M., Copeland N.G., Gilbert D.J., Jenkins N.A., Hedrick J., Zlotnik A. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:8205-8210.
59. Strong J.A., Xie W., Coyle D.E., Zhang J.M. Microarray analysis of rat sensory ganglia after local inflammation implicates novel cytokines in pain. PLoS One 2012, 7:e40779.
60. Trotti D., Rossi D., Gjesdal O., Levy L.M., Racagni G., Danbolt N.C., Volterra A. Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 1996, 271:5976-5979.
61. Ungard R.G., Seidlitz E.P., Singh G. Oxidative stress and cancer pain. Can. J. Physiol. Pharmacol. 2013, 91:31-37.
62. van den Beuken-van Everdingen M.H., de Rijke J.M., Kessels A.G., Schouten H.C., van Kleef M., Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40years. Ann. Oncol. 2007, 18:1437-1449.
63. van Weering H.R., Boddeke H.W., Vinet J., Brouwer N., de Haas A.H., van Rooijen N., Thomsen A.R., Biber K.P. CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus. Hippocampus 2011, 21:220-232.
64. Vanguri P. Interferon-gamma-inducible genes in primary glial cells of the central nervous system: comparisons of astrocytes with microglia and Lewis with brown Norway rats. J. Neuroimmunol. 1995, 56:35-43.
65. Vlkolinský R., Siggins G.R., Campbell I.L., Krucker T. Acute exposure to CXC chemokine ligand 10, but not its chronic astroglial production, alters synaptic plasticity in mouse hippocampal slices. J. Neuroimmunol. 2004, 150:37-47.
66. Wang L.N., Yao M., Yang J.P., Peng J., Peng Y., Li C.F., Zhang Y.B., Ji F.H., Cheng H., Xu Q.N., Wang X.Y., Zuo J.L. Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord. Mol. Pain 2011, 7:48.
67. Wang L.N., Yang J.P., Ji F.H., Zhan Y., Jin X.H., Xu Q.N., Wang X.Y., Zuo J.L. Brain-derived neurotrophic factor modulates N-methyl-d-aspartate receptor activation in a rat model of cancer-induced bone pain. J. Neurosci. Res. 2012, 90:1249-1260.
68. Wang X.W., Li T.T., Zhao J., Mao-Ying Q.L., Zhang H., Hu S., Li Q., Mi W.L., Wu G.C., Zhang Y.Q., Wang Y.Q. Extracellular signal-regulated kinase activation in spinal astrocytes and microglia contributes to cancer-induced bone pain in rats. Neuroscience 2012, 217:172-181.
69. Xu J., Zhu M.D., Zhang X., Tian H., Zhang J.H., Wu X.B., Gao Y.J. NFκB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice. J. Neuroinflammation 2014, 11:38.
70. Yin Q., Cheng W., Cheng M.Y., Fan S.Z., Shen W. Intrathecal injection of anti-CX3CR1 neutralizing antibody delayed and attenuated pain facilitation in rat tibial bone cancer pain model. Behav. Pharmacol. 2010, 21:595-601.
71. Zanelli S.A., Ashraf Q.M., Delivoria-Papadopoulos M., Mishra O.P. Peroxynitrite-induced modification of the N-methyl-d-aspartate receptor in the cerebral cortex of the guinea pig fetus at term. Neurosci. Lett. 2000, 296:5-8.
72. Zanelli S.A., Ashraf Q.M., Mishra O.P. Nitration is a mechanism of regulation of the NMDA receptor function during hypoxia. Neuroscience 2002, 112:869-877.
73. Zhao Z., Fan H., Higgins T., Qi J., Haines D., Trivett A., Oppenheim J.J., Wei H., Li J., Lin H., Howard O.M. Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways. Cancer Lett. 2014, 355:232-241.